Comparing a patient’s tumor DNA sequence with that of her normal tissue can improve researchers’ identification of disease-associated mutations.
↧
Cancer Sequencing Controls | The Scientist Magazine®
↧
Channel:
Sciences & Santé | Scoop.it
© 2025 //www.rssing.com